Invention Grant
- Patent Title: Anti-CTLA4 antibodies and uses thereof
-
Application No.: US17181454Application Date: 2021-02-22
-
Publication No.: US12054547B2Publication Date: 2024-08-06
- Inventor: Yi Yang , Yanan Guo , Xiaodong Cheng , Yunyun Chen , Jingshu Xie , Chunyan Dong , Fang Yang , Chengyuan Lu , Yuelei Shen , Jian Ni
- Applicant: Eucure (Beijing) Biopharma Co., Ltd
- Applicant Address: CN Beijing
- Assignee: Eucure (Beijing) Biopharma Co., Ltd.
- Current Assignee: Eucure (Beijing) Biopharma Co., Ltd.
- Current Assignee Address: CN Beijing
- Agency: Fish & Richardson P.C.
- The original application number of the division: US16815560 2020.03.11
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61P35/00 ; A61K39/00
Abstract:
This disclosure relates to anti-cytotoxic T-lymphocyte-associated protein 4 (CTLA4 or CTLA-4) antibodies, antigen-binding fragments, and the uses thereof.
Public/Granted literature
- US20210188981A1 ANTI-CTLA4 ANTIBODIES AND USES THEREOF Public/Granted day:2021-06-24
Information query
